Repligen (RGEN) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.32% |
| Dec 31, 2025 | 5.28% |
| Sep 30, 2025 | -0.72% |
| Jun 30, 2025 | 2.60% |
| Mar 31, 2025 | -5.74% |
| Dec 31, 2024 | -61.20% |
| Sep 30, 2024 | -21.86% |
| Jun 30, 2024 | -1.26% |
| Mar 31, 2024 | -18.88% |
| Dec 31, 2023 | -22.96% |
| Sep 30, 2023 | 11.44% |
| Jun 30, 2023 | 49.21% |
| Mar 31, 2023 | 32.31% |
| Dec 31, 2022 | -131.75% |
| Sep 30, 2022 | 91.08% |
| Jun 30, 2022 | 74.87% |
| Mar 31, 2022 | 70.69% |
| Dec 31, 2021 | -100.12% |
| Sep 30, 2021 | 79.48% |
| Jun 30, 2021 | 52.53% |
| Mar 31, 2021 | 67.11% |
| Dec 31, 2020 | 65.39% |
| Sep 30, 2020 | 36.98% |
| Jun 30, 2020 | 29.78% |
| Mar 31, 2020 | 20.52% |
| Dec 31, 2019 | 78.17% |
| Sep 30, 2019 | -5.82% |
| Jun 30, 2019 | 24.29% |
| Mar 31, 2019 | 14.27% |
| Dec 31, 2018 | 5.67% |
| Sep 30, 2018 | -4.05% |
| Jun 30, 2018 | -11.01% |
| Mar 31, 2018 | 4.79% |
| Dec 31, 2017 | -24.75% |
| Sep 30, 2017 | -25.63% |
| Jun 30, 2017 | 15.50% |
| Sep 30, 2016 | 29.62% |
| Jun 30, 2016 | 151.02% |
| Mar 31, 2016 | 26.59% |
| Dec 31, 2015 | 26.00% |
| Sep 30, 2015 | 42.63% |
| Jun 30, 2015 | 34.51% |